文献速递多重用药老年综合评估

全科医生主导的社区老年人减药干预:一项探索性对照试验

GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial.
PubMed 文献 · J Am Geriatr Soc · 2019-12-02

该研究在澳大利亚昆士兰东南部5家全科诊所开展实用性对照前后设计,评估全科医生主导的多组分减药干预在社区老年人中的可行性、有效性和安全性。干预组78例、常规护理组67例,随访18周,干预组每人停用或减量的常规药物数多于常规护理组,组间差异有统计学意义,且未观察到重大安全事件。

要点

  • 全科医生主导的多组分减药干预在社区老年人中可行,且未发生重大安全事件。
  • 干预组每人停用或减量常规药物数高于常规护理组,差异有统计学意义。
  • 补充剂、抑酸药、他汀类、口服降糖药和利尿剂是较常被减停的药物类别。

核心结论

  • 全科医生主导的减药干预在社区老年人中可行,效果中等,且未伴随重大安全事件。

研究设计与样本

  • 实用性、对照、前后设计,在澳大利亚昆士兰东南部5家全科诊所开展。
  • 干预组包括3家诊所的10名全科医生、2名药师和78例患者;常规护理组包括2家诊所的10名全科医生和67例患者。
  • 纳入患者年龄65岁及以上、定期处方药物5种及以上、能以英语参加电话访谈。
  • 干预包括5小时互动式减药培训工作坊、全科医生与患者延长减药咨询并使用标准化软件模板、以及全科医生酌情安排药师全面药物审查。
  • 主要结局为18周随访期内每例患者停用或减量的常规药物数的组间平均差异。

主要发现

  • 研究完成时,干预组每人停用或减量常规药物数均值(SD)为0.99(1.23),常规护理组为0.43(0.84),平均差异为0.55(95%CI=-0.90至-0.21;P=.002)。
  • 粗计数显示干预组649种常规药物中77种(11.9%)被停用或减量,常规护理组571种中29种(5.1%)被停用或减量(P<.001)。
  • 补充剂、抑酸药、他汀类、口服降糖药和利尿剂是较常被减停的药物类别。
  • 两组在新启用药物数、自报非计划住院或健康相关生活质量恶化方面无统计学显著差异。
  • 部分干预组患者在研究结束时报告对其用药必要性和适当性有更大确定性。

关键数值与推荐

  • 纳入标准:年龄65岁及以上、定期处方药物5种及以上、能以英语参加电话访谈。
  • 主要结局:18周随访期内每例患者停用或减量的常规药物数,干预组均值(SD)0.99(1.23)vs 常规护理组0.43(0.84),平均差异0.55(95%CI=-0.90至-0.21;P=.002)。
  • 药物层面粗计数:干预组77/649(11.9%)vs 常规护理组29/571(5.1%)常规药物被停用或减量(P<.001)。

临床怎么用

  • 对社区居住、定期使用5种及以上药物的65岁及以上老年人,可考虑由全科医生主导的多组分减药干预。
  • 干预可包括对临床医生进行互动式减药培训、延长减药咨询并使用标准化软件模板、以及酌情安排药师全面药物审查。
  • 减药时可优先关注补充剂、抑酸药、他汀类、口服降糖药和利尿剂等较常被减停的药物类别。

局限性

  • 研究为探索性、实用性、对照、前后设计,非随机对照试验。
  • 研究仅在澳大利亚昆士兰东南部5家全科诊所开展,样本量有限。
  • 患者需能以英语参加电话访谈,可能限制结果的推广性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess feasibility, effectiveness, and safety of a multifaceted general practitioner (GP) led intervention to reduce potentially inappropriate polypharmacy in community-living older people. DESIGN: Pragmatic, controlled, pre-post design. SETTING: Five general practices in southeast Queensland, Australia. PARTICIPANTS: Ten GPs from three practices, two pharmacists, and 78 patients comprised the intervention group, and 10 GPs from two practices and 67 patients comprised the usual care group. Patients were aged 65 years or older, receiving five or more regularly prescribed medicines, and capable of participating in telephone interviews in English. INTERVENTION: A 5-hour interactive deprescribing training workshop for clinicians; an extended deprescribing consultation between GPs and enrolled patients, entailing a comprehensive review of their medicines using a standardized software template codesigned by GPs; and comprehensive medicine review by a pharmacist, at the GP's discretion. OUTCOME MEASURES: Primary outcome was mean difference in number of regular medicines deprescribed (ie, ceased or dose reduced) per patient over an 18-week follow-up period. Medicine-specific and patient-reported outcomes, safety, and process measures were also evaluated. RESULTS: At study completion, mean (SD) number of regular medicines deprescribed per patient was 0.99 (1.23) in the intervention group vs 0.43 (0.84) in the usual care group, equaling a mean difference of 0.55 (95% confidence interval = -0.90 to -0.21; P = .002). Crude totals showed 77 of 649 (11.9%) vs 29 of 571 (5.1%) regular medicines deprescribed in intervention and usual care groups, respectively (P < .001). Supplements, gastric acid suppressants, statins, oral hypoglycemics, and diuretics were medicine classes more frequently deprescribed. There were no statistically significant between-group differences in numbers of medicines commenced, self-reported unplanned hospitalizations, or worsened health-related quality of life. A subset of intervention patients reported greater certainty in the necessity and appropriateness of their medicines at study end. CONCLUSION: The deprescribing intervention appears feasible, was modestly effective, and was not associated with any major safety events. J Am Geriatr Soc 68:403-410, 2020.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Anderson K, Freeman C, Foster M, et al. GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial. J Am Geriatr Soc. 2019. PMID: 31792947. doi:10.1111/jgs.16273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。